9 News & Press Releases found
Biolargo, Inc. News
-
BioLargo Secures Financing for Its Advanced Wound Care Products Targeting FDA Application, Approval and Commercialization Through Its Subsidiary Clyra Medical Technologies
BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to ...
-
BioLargo issued patent for its platform of liquid and hydrogel iodine technologies
BioLargo, Inc. (OTCQB: BLGO) announced today the United States Patent and Trademark Office issued patent 8,846,067 titled “antimicrobial solutions and methods” which covers the use of BioLargo’s iodine technology in its platform of ...
-
BioLargo`s Odor-No-More Gains More Traction with its Largest Government Order to Date
BioLargo, Inc. (OTCQB: BLGO) announced today its Odor-No-More subsidiary was awarded a contract for 885 cases (total order approximately $50,000) of its Specimen Transport Solidifier Pouches from the U.S. Defense Logistics Agency (DLA - ...
-
BioLargo to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
BioLargo, Inc. (OTCQB: BLGO) will present at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, September 9th at the New York Palace Hotel. Dennis Calvert, BioLargo`s president, is scheduled to present at 2:55 p.m. ET. A ...
-
BioLargo Featured in SNN Live Interviews
BioLargo, Inc.`s president and CEO Dennis Calvert was recently interviewed by SNN Live at two investor conferences. Mr. Calvert introduces BioLargo and discusses the company`s progress in commercializing its advanced iodine platform technology. ...
-
BioLargo Assigned Federal and Military Supply System National Stock Number
Opens recurring sales channels for health care related products - Establishes working capital line of credit to support sales efforts - BioLargo, Inc. (OTCQB: BLGO) announced its subsidiary Odor-No-More, Inc. was assigned National Stock ...
-
BioLargo`s product wins cat fancy magazine editor`s choice award
BioLargo, Inc. (OTCQB: BLGO) today announced that Cat Fancy Magazine awarded its Litter Deodorizing Concentrate an "Editor`s Choice Award," naming it one of the 18 "Best Products of the Year" for 2013. Detailed in the December issue on newsstands ...
-
BioLargo Adds Wound Management Expert and Former VP at Smith & Nephew, Tanya Rhodes, to Its Team
BioLargo, Inc. (OTCBB: BLGO) announced today that former Smith & Nephew Vice President of Innovation (and Vice President at Smith & Nephew Wound Management) Tanya Rhodes has joined the BioLargo management team as a senior strategy advisor. ...
-
BioLargo’s CupriDyne®: A Platform Technology
What do Microsoft Corporation (NASDAQ: MSFT), Micromet Inc. (NASDAQ: MITI) and BioLargo Inc. (OTCBB: BLGO) have in common? The answer: A platform technology. The Value of Platform Technologies Platform technologies are defined as those ...